- Filed
- May 15, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 11, 2025 | 15.43M sh |
| Shares Diluted | Q1 2025 · Mar 31, 2025 | 14.99M sh |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 14.42M sh |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $12.88M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $13.32M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $20.08M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $20.17M |
| Total Liabilities restated | Q1 2025 · Mar 31, 2024 | $28.75M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $23.64M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $27.13M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $46.76M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $61.46M |
| Total Assets restated | Q1 2025 · Mar 31, 2024 | $75.65M |
| Eps Diluted | Q1 2025 · Mar 31, 2025 | −$1.04 |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.21 |
| Capex | Q1 2025 · Mar 31, 2024 | $104K |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$3.03M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $46.9M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $49.54M |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.21 |
| Net Income | Q1 2025 · Mar 31, 2024 | −$3.04M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$3.05M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $1.48M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $13.08M |